Breathe Technologies inhale $15m in series B:
This article was originally published in Clinica
Breath Technologies, a Fremont, California company focusing on respiratory disorders, has secured $15m in its second round of venture financing. The round was led by Kleiner Perkins Caufield & Byers. Breathe is developing a range of compact, ultra-lightweight ventilator systems for the hospital, homecare and pandemic markets.
You may also be interested in...
Celltrion has accelerated the development of its antiviral treatment for COVID-19 and aims to launch a rapid self-testing kit that could provide results within 15-20 minutes. The Korean firm also plans to develop a ‘super antibody’ to prepare for potential future pandemic situations.
Paracetamol, acetylcysteine and loperamide among list of OTC drugs deemed "essential" by Spain in the fight against coronavirus.
Mylan, in partnership with Indian firm Lupin, will be looking to rival Biogen and Sandoz by introducing an etanercept biosimilar in European markets following a positive opinion by the EMA’s CHMP on Mylan's application.